Lincoln Pharmaceuticals consolidated net profit rises 29.75% in the December 2023 quarter
Sales rise 9.48% to Rs 146.45 crore
Net profit of Lincoln Pharmaceuticals rose 29.75% to Rs 28.04 crore in the quarter ended December 2023 as against Rs 21.61 crore during the previous quarter ended December 2022. Sales rose 9.48% to Rs 146.45 crore in the quarter ended December 2023 as against Rs 133.77 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales146.45133.77 9 OPM %20.2520.00 -PBDT40.5232.78 24 PBT37.7130.51 24 NP28.0421.61 30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 08 2024 | 12:45 PM IST